Ipsen and Marengo Therapeutics Inc, a clinical-stage biotech company, announced the expansion of their ongoing oncology research partnership, to include TriSTAR, Marengo’s next-generation, precision...
Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
